| Description | Bevurogant is an antagonist of RORγt receptor and can be used in studies about the treatment of chronic inflammatory diseases. |
| molecular weight | 532.62 |
| Molecular formula | C26H28N8O3S |
| CAS | 1817773-66-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 245 mg/mL (459.99 mM), Sonication is recommended. |
| References | 1. BAKONYI J, et, al. Compounds as modulators of ror gamma. US20150291607A1. |